[HTML][HTML] hERG-deficient human embryonic stem cell-derived cardiomyocytes for modelling QT prolongation

Y Chang, Y Li, R Bai, F Wu, S Ma, A Saleem… - Stem cell research & …, 2021 - Springer
Background Long-QT syndrome type 2 (LQT2) is a common malignant hereditary
arrhythmia. Due to the lack of suitable animal and human models, the pathogenesis of LQT2 …

Current advances in human-induced pluripotent stem cell-based models and therapeutic approaches for congenital heart disease

M Cao, Y Liu, Y Sun, R Han, H Jiang - Molecular and Cellular …, 2024 - Springer
Congenital heart disease (CHD) represents a significant risk factor with profound
implications for neonatal survival rates and the overall well-being of adult patients. The …

[HTML][HTML] Pathogenic mechanism and gene correction for LQTS-causing double mutations in KCNQ1 using a pluripotent stem cell model

Z Wang, L Wang, W Liu, D Hu, Y Gao, Q Ge, X Liu… - Stem Cell Research, 2019 - Elsevier
Aims To establish a KCNQ1 mutant-specific induced pluripotent stem cell (iPSC) model of a
Chinese inherited long QT syndrome (LQTS) patient and to explore the pathogenesis of …

The influence of hERG1a and hERG1b isoforms on drug safety screening in iPSC-CMs

B Goversen, MKB Jonsson… - Progress in Biophysics …, 2019 - Elsevier
The human Ether-à-go-go Related Gene (hERG) encodes the pore forming subunit of the
channel that conducts the rapid delayed rectifier potassium current I Kr. I Kr drives …

Disease modeling of cardiac arrhythmias using human induced pluripotent stem cells

W Liang, L Gasparyan, W AlQarawi… - Expert opinion on …, 2019 - Taylor & Francis
Introduction: Inherited arrhythmias are an uncommon, but malignant family of cardiac
diseases that result from genetic abnormalities in the ion channels and/or structural proteins …

Induced pluripotent stem cells as a platform to understand patient‐specific responses to opioids and anaesthetics

D Obal, JC Wu - British journal of pharmacology, 2020 - Wiley Online Library
Recent advances in human induced pluripotent stem cell (iPSC) technology may provide
unprecedented opportunities to study patient‐specific responses to anaesthetics and …

[HTML][HTML] Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome

G Mondéjar-Parreño, JWS Jahng, N Belbachir, BC Wu… - Stem cell …, 2021 - Elsevier
Congenital long QT syndrome type 2 (LQT2) results from KCNH2 mutations that cause loss
of Kv11. 1 channel function which can lead to arrhythmias, syncope, and sudden death …

[HTML][HTML] Deciphering common long QT syndrome using CRISPR/Cas9 in Human-induced pluripotent stem cell-derived cardiomyocytes

Y Song, Z Zheng, J Lian - Frontiers in cardiovascular medicine, 2022 - frontiersin.org
From carrying potentially pathogenic genes to severe clinical phenotypes, the basic
research in the inherited cardiac ion channel disease such as long QT syndrome (LQTS) …

The Advantages, Challenges, and Future of Human-Induced Pluripotent Stem Cell Lines in Type 2 Long QT Syndrome

D Cai, Z Zheng, X Jin, Y Fu, L Cen, J Ye, Y Song… - Journal of …, 2023 - Springer
Type 2 long QT syndrome (LQT2) is the second most common subtype of long QT syndrome
and is caused by mutations in KCHN2 encoding the rapidly activating delayed rectifier …

Introducing AHA's New President: Joseph C. Wu, MD, PhD, FAHA

BM Kuehn - Journal of the American Heart Association, 2023 - Am Heart Assoc
Radiology and Director of Stanford Cardiovascular Institute, was drawn to cardiology
because he was fascinated by the beating heart—“the center of melodic, rhythmic motion …